Jump to navigation
Pharmacological inhibition of GLUT1 as a new immunotherapeutic approach after myocardial infarction. Chen Z, Dudek J, Maack C, Hofmann U. Biochem Pharmacol. 2021 Aug;190:114597. doi: 10.1016/j.bcp.2021.114597. Epub 2021 May 13.